Validation of the Hematopoietic Cell Transplantation-Specific Comorbidity Index (HCT-CI) in Single and Multiple Institutions: Limitations and Inferences-Reference-Cited by-同舟云学术

Validation of the Hematopoietic Cell Transplantation-Specific Comorbidity Index (HCT-CI) in Single and Multiple Institutions: Limitations and Inferences

Published:2009-06 Issue:6 Volume:15 Page:757-758
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Sorror Mohamed L.,Storer Barry,Storb Rainer F.

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference15 articles.

1. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT;Sorror;Blood,2005

2. Does the hematopoietic cell transplantation specific comorbidity index predict transplant outcomes? A validation study in a large cohort of umbilical cord blood and matched related donor transplants;Majhail;Biol Blood Marrow Transplant,2008

3. Utility of comorbidity assessment in predicting transplantation-related toxicity following autologous hematopoietic stem cell transplantation for multiple myeloma;Labonté;Biol Blood Marrow Transplant,2008

4. Hematopoietic cell transplantation-specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences;Sorror;Blood,2007

5. Outcomes of alemtuzumab-based reduced intensity conditioning stem cell transplantation using unrelated donors for myelodysplastic syndromes;Lim;Br J Haematol,2006

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differences in Acute Graft-Versus-Host Disease (GVHD) Severity and Its Outcomes Between Black and White Patients;Transplantation and Cellular Therapy;2024-09

2. Novel MAGIC composite scores using both clinical symptoms and biomarkers best predict treatment outcomes of acute GVHD;Blood;2024-08-29

3. Adjusting diffusing capacity for anemia in patients undergoing allogeneic HCT: a comparison of two methodologies;Current Research in Translational Medicine;2024-06

4. Flares of acute graft-versus-host disease: a Mount Sinai Acute GVHD International Consortium analysis;Blood Advances;2024-04-23

5. Preconditioning Frailty Phenotype Influences Survival and Relapse for Older Allogeneic Transplantation Recipients;Transplantation and Cellular Therapy;2024-04